CVS to hire 15,000 to help with COVID-19, flu




imageStock Markets6 hours ago (Oct 19, 2020 01:00PM ET)
image

CVS is preparing for a winter season that could be busier than usual.

The drug store chain on Monday said it plans to hire 15,000 additional workers in the fourth quarter to help out with what it sees as a likely increase in demand for health services as the winter months could fuel a resurgence in the spread of COVID-19, coupled with a normal uptick due to flu season.

More than 10,000 of those additional jobs will be for full-time and part-time licensed pharmacy technicians that could help administer COVID-19 tests and vaccines at CVS locations around the country.

No vaccine has been approved yet for distribution, but there are several vaccines in late-stage clinical trials, fueling hope a vaccine could be approved before the year is out.

The hiring spree announced Monday at CVS comes on top of the 50,000 new employees the drug store chain said it would take on back in March to help customers battle the outbreak.

CVS to hire 15,000 to help with COVID-19, flu

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

image

Our Apps

DOWNLOAD APPApp store

Investing.com

(C) 2007-2020 Fusion Media Limited. All Rights Reserved

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.

Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.

It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.